Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F13ST
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,812
Award facts
- Contract value 100% obligated
- $11,812.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,812.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 23, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of January 26, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor used in the treatment of high cholesterol and cardiovascular disease management, representing a critical pharmaceutical supply for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a vast range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support military healthcare programs worldwide. AmerisourceBergen's position as a prime pharmaceutical vendor for DLA underscores its critical role in the federal medical supply chain serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F13ST?
SPE2DR26F13ST was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F13ST worth?
The government has obligated $11,812 on SPE2DR26F13ST.
Is contract SPE2DR26F13ST an order under another contract?
Yes. SPE2DR26F13ST is a delivery order under SPE2DR25D1110, an indefinite delivery contract.
Was contract SPE2DR26F13ST competed?
The extent of competition for SPE2DR26F13ST was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award